Skip to content

Study of IVC Filter Retrieval With the Günther Tulip Vena Cava Filter

A Non-Randomized Prospective Study of IVC Filter Retrieval

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00196118
Enrollment
800
Registered
2005-09-20
Start date
2005-04-30
Completion date
2007-07-31
Last updated
2007-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Embolism, Venous Thromboembolism

Keywords

Pulmonary Embolism, Venous Thromboembolism, Inferior Vena Cava Filter, IVC, PE

Brief summary

The purpose of this study is to test the hypothesis that the Günther Tulip Vena Cava Filter can be removed after a period of implantation, when implanted in patients for the prevention of pulmonary thromboembolism.

Interventions

DEVICEGünther Tulip Vena Cava Filter

Sponsors

Cook Group Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient must be considered at high risk for PE, but placement of a permanent IVC filter is not likely to be required. * Patient must have a patent internal jugular vein. * Patient has given informed consent.

Exclusion criteria

* Patient is less than 18 years. * Patient has a pre-existing filter * Patient had indications for a permanent filter at the time of the initial evaluation. * Patient has uncontrollable coagulopathy. * Patient has a short life expectancy \< 6 months. * Patient has metastatic malignancy. * Patient has a vena cava diameter over 30 mm, measured by vena cava sizing catheters. * Patient has a contrast allergy that cannot be adequately pre-medicated. * Patient is at risk of septic embolism. * Patient has sepsis. * Patient has a hypersensitivity to any of the components of the GT filter, specifically cobalt, nickel, and chromium. * Patient has impaired renal function (creatinine \> 2.0). * Patient is pregnant or planning to become pregnant within the next 6 months

Design outcomes

Primary

MeasureTime frame
The rate of successful filter retrieval following implant.

Secondary

MeasureTime frame
The rate of complications related to Inferior Vena Cava Filter use.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026